Optimal Treatment for Coronary Drug Eluting Stent In-stent Restenosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Optimal Treatment for Coronary Drug Eluting Stent In-stent Restenosis — Stella

Recruiting

Back to Coronary Stent Restenosis trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Hungary

Semmelweis University Heart and Vascular Center, Budapest, Budapest

University of Szeged, Department of Invasive Cardiology, Szeged, Csongád-Csanád

Key details

Sponsor

Semmelweis University Heart and Vascular Center

Enrollment target

~150 participants

Started

April 2021

Primary completion

January 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 85 Years

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov